An international panel of experts discussed recent outcomes from the GIANT Study (Greatest International Antibiotic Trial) which was set up to evaluate the impact on the patients with acute exacerbations of chronic bronchitis (AECB), as well as the effica An international panel of experts discussed recent outcomes from the GIANT Study (Greatest International Antibiotic Trial) which was set up to evaluate the impact on the patients with acute exacerbations of chronic bronchitis (AECB), as well as the effica